Drug interaction prediction method based on double-view graph neural network
Through a method based on a dual-view graph neural network, combining the molecular structure and chemical substructure information of the drug, adaptively captures the key substructure of drug interactions, solving the limitations of DDI prediction in the prior art and achieving more efficient and accurate drug interaction prediction.
Patent Information
- Application Number
- CN202411791068.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-06
- Publication Date
- 2025-03-25
AI Technical Summary
The prior art has limitations in predicting drug-drug interactions (DDIs), such as relying on a large number of biological experiments, time-consuming, high cost and limited sensitivity and specificity.
Using a method based on a dual-view graph neural network, combining the molecular structure information and chemical substructure information of the drug, the key substructure of interaction between the two drugs is adaptively captured through the directional message delivery neural network and the graph attention network with the substructure attention mechanism, and the interaction score between each pair of substructures between the two drugs is calculated through the self-attention graph pooling layer, thereby predicting the interaction probability between the two drugs.
It improves the accuracy and robustness of drug interaction prediction, simplifies the drug development process, and provides a safer drug combination.